Wednesday, July 22, 2020 7:14:12 PM
Based on the above capitalization information, only 28,466,935 shares of our currently authorized common stock remained unissued and unreserved and available for future issuance as of June 9, 2020.
So, 176 + 96 = 271 million of the 300 million currently authorized are already committed. Leaving the 28 Million.
Re-calculate settlement using 271 million outstanding and watch the settlement share price drop like a rock.
And that's if he does not issue any more from the extra 150 million being increased at the vote.
That's an extra 250 million that nobody has accounted for.
250 MILLION SHARES
Recent NLST News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:31:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:15 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 09:54:43 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 02:44:15 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/01/2024 09:35:01 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 03/01/2024 09:32:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 01:15:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 02:38:35 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/16/2024 02:52:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 12:30:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/09/2023 01:30:09 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/06/2023 02:22:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2023 08:30:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2023 01:30:21 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2023 09:01:19 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/15/2023 09:00:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 12:00:12 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/11/2023 01:53:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 08:45:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 12:30:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/18/2023 01:30:27 AM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM